AWARE INC/MASS (AWRE)

US05453N1000 - Common Stock

1.71  -0.02 (-1.16%)

Fundamental Rating

3

Taking everything into account, AWRE scores 3 out of 10 in our fundamental rating. AWRE was compared to 276 industry peers in the Software industry. AWRE has a great financial health rating, but its profitability evaluates not so good. AWRE has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

AWRE had negative earnings in the past year.
AWRE had a positive operating cash flow in the past year.
In the past 5 years AWRE always reported negative net income.
In the past 5 years AWRE reported 4 times negative operating cash flow.

1.2 Ratios

AWRE has a worse Return On Assets (-15.81%) than 62.04% of its industry peers.
With a Return On Equity value of -21.34%, AWRE perfoms like the industry average, outperforming 48.18% of the companies in the same industry.
Industry RankSector Rank
ROA -15.81%
ROE -21.34%
ROIC N/A
ROA(3y)-10.4%
ROA(5y)-12.09%
ROE(3y)-13.21%
ROE(5y)-14.38%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 93.04%, AWRE belongs to the best of the industry, outperforming 99.27% of the companies in the same industry.
In the last couple of years the Gross Margin of AWRE has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for AWRE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 93.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y0.15%

8

2. Health

2.1 Basic Checks

AWRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
AWRE has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, AWRE has less shares outstanding
There is no outstanding debt for AWRE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of 0.53, we must say that AWRE is in the distress zone and has some risk of bankruptcy.
AWRE has a Altman-Z score of 0.53. This is in the lower half of the industry: AWRE underperforms 66.79% of its industry peers.
AWRE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.53
ROIC/WACCN/A
WACC9.92%

2.3 Liquidity

A Current Ratio of 4.75 indicates that AWRE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.75, AWRE belongs to the top of the industry, outperforming 87.96% of the companies in the same industry.
A Quick Ratio of 4.75 indicates that AWRE has no problem at all paying its short term obligations.
AWRE has a Quick ratio of 4.75. This is amongst the best in the industry. AWRE outperforms 87.96% of its industry peers.
Industry RankSector Rank
Current Ratio 4.75
Quick Ratio 4.75

1

3. Growth

3.1 Past

The earnings per share for AWRE have decreased strongly by -212.50% in the last year.
AWRE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.95%.
The Revenue has been growing slightly by 2.49% on average over the past years.
EPS 1Y (TTM)-212.5%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q12.5%
Revenue 1Y (TTM)13.95%
Revenue growth 3Y17.28%
Revenue growth 5Y2.49%
Revenue growth Q2Q7.73%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y10.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.07%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AWRE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AWRE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, AWRE is valued cheaply inside the industry as 85.77% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.95
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AWRE!.
Industry RankSector Rank
Dividend Yield N/A

AWARE INC/MASS

NASDAQ:AWRE (4/26/2024, 7:00:00 PM)

1.71

-0.02 (-1.16%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap36.05M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.81%
ROE -21.34%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 93.04%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.75
Quick Ratio 4.75
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-212.5%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y10.24%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)13.95%
Revenue growth 3Y17.28%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y